(1) Sohrabi C, Alsafi Z, O’Neill N, Khan M, Kerwan A, Al-Jabir A, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID–19). International Journal of Surgery. 2020;.
(2) The World Health Organisation. Coronavirus disease (COVID–19) outbreak. [homepage on the Internet]. 2020 [updated May/05; cited 2020 May/05]. Available from: https://www.who.int/westernpacific/emergencies/covid–19.
(3) The World Health Organisation. Coronavirus disease (COVID–19) Pandemic. [homepage on the Internet]. World Health Organisation; 2020 [updated April/26; cited 2020 April/26]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus–2019.
(4) World Health Organization. WHO Director-General’s opening remarks at the media briefing on COVID–19–11 March 2020. Geneva, Switzerland. 2020;.
(5) Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID–19) outbreak–an update on the status. Military Medical Research. 2020; 7(1):1–10.
(6) Moore CA, Staples JE, Dobyns WB, Pessoa A, Ventura CV, Da Fonseca EB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA pediatrics. 2017; 171(3):288–295.
(7) Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika virus and birth defects—reviewing the evidence for causality. New England Journal of Medicine. 2016; 374(20):1981–1987.
(8) Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020; 395(10223):497–506.
(9) Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. New England journal of medicine. 2020; 382(18):1708–1720.
(10) Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID–19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. Jama. 2020; 323(13):1239–1242.
(11) Yang S, Cao P, Du P, Wu Z, Zhuang Z, Yang L, et al. Early estimation of the case fatality rate of COVID–19 in mainland China: a data-driven analysis. Annals of Translational Medicine. 2020; 8(4).
(12) Surveillances V. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID–19)—China, 2020. China CDC Weekly. 2020; 2(8):113–122.
(13) Adhikari SP, Meng S, Wu Y, Mao Y, Ye R, Wang Q, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID–19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020; 9(1):1–12.
(14) Lai C, Shih T, Ko W, Tang H, Hsueh P. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV–2) and corona virus disease–2019 (COVID–19): the epidemic and the challenges. International journal of antimicrobial agents. 2020;:105924.
(15) Mullins E, Evans D, Viner R, O’Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound in Obstetrics & Gynecology. 2020;.
(16) The Royal College of Obstetricians and Gynaecologists (RCOG). Coronavirus (COVID–19) Infection in Pregnancy. London, United Kingdom: Royal College of Obstetricians and Gynaecologists; 2020.
(17) Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, et al. Mortality of a pregnant patient diagnosed with COVID–19: A case report with clinical, radiological, and histopathological findings. Travel Medicine and Infectious Disease. 2020;:101665.
(18) Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV–2 infection during pregnancy. The Journal of infection. 2020;.
(19) Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID–19 infection in nine pregnant women: a retrospective review of medical records. The Lancet. 2020; 395(10226):809–815.
(20) Wang1a X, Zhou2a Z, Zhang J, Zhu F, Tang Y, Shen X, et al. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. 2020;.
(21) Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Translational pediatrics. 2020; 9(1):51.
(22) Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic Management of COVID–19 Patients: A systematic review. Infection Prevention in Practice. 2020;:100061.
(23) Gautret P, Lagier J, Parola P, Meddeb L, Mailhe M, Doudier B, et al. Hydroxychloroquine and azithromycin as a treatment of COVID–19: results of an open-label non-randomized clinical trial. International journal of antimicrobial agents. 2020;:105949.
(24) Della Gatta AN, Rizzo R, Pilu G, Simonazzi G. COVID19 during pregnancy: a systematic review of reported cases. American Journal of Obstetrics and Gynecology. 2020;.
(25) Thomas B, Al Hail M, Abdulrouf P, Elkassem W, Tarannum A, Al Hail F, Rijims M, Parappil H, Stewart D. Clinical characteristics, maternal and perinatal outcomes and safety of therapeutic interventions during Covid–19: a systematic review protocol. 23 April. [serial on the Internet] 2020 PROSPERO International prospective register of systematic reviews(CRD42020181163):5th March 2020. Available from: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID = 181163.
(26) Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015; 4(1):1.
(27) McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. Journal of clinical epidemiology. 2016; 75:40–46.
(28) Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ (Clinical research ed.). 2011; 343:d5928.
(29) Wells G, Shea B, O’connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Quality Assessment Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Clin Epidemiol [Internet]. 2017;:1–2.
(30) Murad MH, Sultan S, Haffar S, Bazerbachi F. Methodological quality and synthesis of case series and case reports. BMJ evidence-based medicine. 2018; 23(2):60–63.
(31) GRADE Working Group. Grading of recommendations assessment, development and evaluation. 2017.